A population-based study of the costs of care for community-acquired pneumonia

Bartolomé, Maria; Almirall, Jordi; Morera, Josep; Pera, Guillem; Rubio, Vicente Ortún; Bassa, J.; Bolíbar, Ignasi; Balanzó, Xavier; Verdaguer, Albert

doi:10.1183/09031936.04.00076704

Cited by 69 publications

(75 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the present study, the documented costs were slightly higher than those reported in the national and European literature. In other studies carried out in Spain, the direct costs of in-patient care were J1,210 [8] and J1,553 [7]. In Europe, the direct costs ranged from J1,333…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Determinants of hospital costs in community-acquired pneumonia

Reyes¹,

Martínez²,

Valles³

et al. 2008

Eur Respir J

View full text Add to dashboard Cite

Community-acquired pneumonia (CAP) has a high incidence and involves an important consumption of healthcare resources. The present authors analysed the influence of comorbidity, initial severity and complications upon the direct costs associated with hospitalised CAP patients.Direct hospitalisation costs (room cost, treatment, laboratory and diagnostic tests) were assessed in a prospective, observational study of 271 patients admitted to a hospital ward due to CAP.The mean¡SD patient age was 70¡15 yrs. The mortality rate was 11.1%. Complications were found in 72.3% and comorbidities in 74.9%. The median (interquartile range) total cost was J1,683 (J1,291-2,471) and the component costs were: room cost J1,286 (J857-1,714); laboratory tests J212 (J171-272); treatment J187 (J114-304); and diagnostic procedures J58 (J29-122). Complications and higher Pneumonia Severity Index increased the costs, but age and comorbidity did not. A logistic regression analysis to predict high cost (.J1,683) showed that infectious (odds ratio 6.8, 95% confidence interval 1.3-36), digestive (5.9 (1.5-22.8)), pulmonary (2.6 (1.4-4.7)) and other complications (3.9 (1.8-8.4)) were independent risk factors, as were previous hospitalisation (2.3 (1.2-4.3)) and hypoalbuminaemia (2 (1.1-3.6)).Complications, hypoalbuminaemia and previous hospitalisation were the main determinants of high direct costs of hospitalisation due to community-acquired pneumonia. Neither age nor comorbidities were independently associated with cost.

show abstract

Section: Discussionmentioning

confidence: 99%

“…In recent years, a number of publications have analysed the economic aspects of CAP, aiming to evaluate costs in outpatients and in those admitted to the hospital or intensive care unit (ICU) [7,8]. BAUER et al [4] also found that direct costs correlated with initial severity as measured by the Pneumonia Severity Index (PSI) [9].…”

mentioning

confidence: 99%

Determinants of hospital costs in community-acquired pneumonia

Reyes¹,

Martínez²,

Valles³

et al. 2008

Eur Respir J

View full text Add to dashboard Cite

show abstract

“…3 But in other study it was found importantly higher expense in patients 65 years of age, but no details were provided on the effect of comorbidity and severity. 11 In the present study it was found that the patient with no comorbidity consumed less cost as compare to the patients with the comorbidity and the cost was found much higher in patient with the comorbidity of cardiovascular disease. Comparing to other study it was determined that co-morbid diseases increased the total cost, but at higher ages (> 65 year) there was no effect on the total cost 4 but in 2001 in another study it was; described that age and co-morbid disease had no effect on the total cost of CAP.…”

mentioning

confidence: 53%

Community Acquired Pneumonia; Assessment of Components of Direct Cost of Treatment of Hospitalized Patients in Karachi

Khan

Naqvi

Sial

et al. 2017

TPMJ

View full text Add to dashboard Cite

ABSTRACT… Background:The treatment cost of community acquired pneumonia in Pakistan is a heavy economic burden for the society. Objectives: To assess the component of direct cost (ward cost, medication cost, laboratory and diagnosis cost and the length of stay cost) of treatment of community acquired pneumonia patients admitted in hospital ward. Study Design: Prospective study. Period: 15 months. Setting: Three private hospitals among these hospitals one of the hospital was a tertiary care university hospital situated in Karachi. Method: The study enrolled 514 patients and the patients were included from three private hospitals. Spearman correlation statistical tool was used to determine the correlation among variables Whitney U test was used to determine the cost in different groups. Results: A total of 514 cases were examined 322 cases were male and 192 cases were females. The CAP cases were mostly prevalent in patients with the age between 1-5 years (192), in male, low socioeconomic status and in unmarried patients. The mean length of hospital stay was 5.31days found in patients admitted in the hospitals due to CAP. In this study the median medication cost of CAP per episode of treatment was Rs 2423($24.25), median laboratory diagnosis cost was found Rs 1310($13.11), median length of stay in hospital cost was found Rs 5700($57.04) and the median total cost of treatment was found Rs 9889($98.96). Conclusion: length of stay, laboratory diagnosis and the medication cost were the main components of direct cost of treatment of hospitalized cap patients. Age, comorbidity, PSI, laboratory diagnosis and length of stay was positively correlated with the direct cost of treatment of CAP. Gender difference was not correlated with the direct cost of treatment of CAP. The direct cost, drug cost, hospital stay cost increases as the pneumonia severity index increases, but in case of laboratory diagnosis cost is initially less in PSI I and increases in the PSI class II but remain same from PSI III to PSI V. Key words:CAP: Community acquired pneumonia, LOS: Length of stay, PSI: Pneumonia severity index. Article Citation: Khan MA, Naqvi BS, Sial AA, Zafar F, Qureshi S. Community acquired pneumonia; assessment of components of direct cost of treatment of hospitalized patients in Karachi. Professional Med J 2017;24(6):843-849.

show abstract

“…El ingreso mensual promedio de IC95%, 2,1-2,8) en casos de neumonías presuntamente bacterianas, con un costo medio de US$ 36,80 (IC95%, 19,5-54,2). Dentro del grupo de "otros" medicamentos administrados se encuentran los líquidos endovenosos, los broncodilatadores, antiemé-ticos, antiulcerosos, vitaminas y protectores cutáneos, entre otros, con un número promedio de administración de 3,8 (IC95%, 3,1-4,6) y un costo de US$ 12,14 (IC95%, 7,[8][9][10][11][12][13][14][15][16]5).…”

Section: Resultsunclassified

“…En la literatura latinoamericana son escasos los estudios económicos que valoren los costos de las neumonías en la población infantil, por lo que puede servir de punto de referencia respecto a América Latina. Los estudios que valoran los costos de las neumonías en países desarrollados se refieren prioritariamente a neumonías en el adulto mayor (12)(13)(14)(15).…”

Section: Discussionunclassified

Costos económicos de las neumonías en niños menores de 2 años de edad, en Colombia

Alvis-Guzmán¹,

Restrepo²,

Higuera

et al. 2005

Rev Panam Salud Publica

View full text Add to dashboard Cite

Objetivos. Analizar los costos de las neumonías presuntamente virales y bacterianas diagnosticadas por radiografía en centros de referencia de tres ciudades colombianas. Métodos. Se estudiaron 128 casos de neumonía (IC95%, 532,80) y los de las presuntamente virales, de 472,20 US$ (IC95%, 331,60) . Las diferencias observadas se explican por los costos directos, en particular de los medicamentos (antibióticos), servicios especiales y pruebas diagnósticas. Dada la similar procedencia de las familias de ambas poblaciones, los costos indirectos no mostraron diferencias y su participación en los costos totales no se consideró relevante. Conclusiones. El estudio reveló diferencias en los costos de la atención de las neumonías presuntamente bacterianas y virales, y se aproximó a los costos indirectos generados por estas entidades patológicas. Tales diferencias permiten inferir que el método de diagnóstico utilizado, que fue la radiografía de tórax, tuvo la capacidad de diferenciar los sucesos de interés. Puesto que en la Región son escasos los estudios económicos que valoren los costos de la neumonía en niños, el presente puede servir de referencia para futuras investigaciones sobre el impacto de las intervenciones en las neumonías.Costos de la atención médica, neumonía, Colombia. RESUMENDe los 10 millones de muertes de menores de 5 años que se registran cada año en el mundo, cerca de 99% ocurren en los países menos desarrollados y 70% de ellas son consecuencia de enfermedades infecciosas. En particular, 1 856 000 de los fallecimientos registrados en este grupo en el año 2002 se atribuyeron a infecciones respiratorias agudas (neumonías en su inmensa mayoría); la cifra no incluye muertes por sarampión, tos ferina ni complica-

show abstract

A population-based study of the costs of care for community-acquired pneumonia

Cited by 69 publications

References 33 publications

Determinants of hospital costs in community-acquired pneumonia

Determinants of hospital costs in community-acquired pneumonia

Community Acquired Pneumonia; Assessment of Components of Direct Cost of Treatment of Hospitalized Patients in Karachi

Costos económicos de las neumonías en niños menores de 2 años de edad, en Colombia

Contact Info

Product

Resources

About